Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Receivables

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 (DMAQR) currently reports a receivables of $1.3M as of March 2026. That compares with $1.6M in the prior-year period — down 16.8% year over year. Use the charts on this page to explore Deep Medicine Acquisition - Tradeable Rights - Oct 2026's receivables history and peer comparisons.

Deep Medicine Acquisition - Tradeable Rights - Oct 2026's receivables decreased from $1.6M to $1.3M — a 16.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 reported $1.3M in receivables as of March 2026. That compares with $1.6M in the prior-year period — down 16.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $1.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Deep Medicine Acquisition - Tradeable Rights - Oct 2026, and consider following DMAQR for alerts when major investors trade the stock.